Treatment for strongyloidiasis is recommended for all persons found to be infected, whether symptomatic or not, due to the risk of developing hyperinfection syndrome and/or disseminated strongyloidiasis. Furthermore, it is recommended that patients be considered for testing prior to being initiated on any immunosuppressive therapy, particularly corticosteroids.

Page last reviewed: December 31, 2018